Literature DB >> 23711710

Continued sustained release of VEGF by PLGA nanospheres modified BAMG stent for the anterior urethral reconstruction of rabbit.

Ji-Hong Wang1, Yue-Min Xu, Qiang Fu, Lu-Jie Song, Chao Li, Qin Zhang, Ming-Kai Xie.   

Abstract

OBJECTIVE: To study the biocompatibility and neovascularization of the PLGA nanospheres wrapped with vascular endothelial growth factor (VEGF), which can improve bladder acellular matrix graft (BAMG) with local continuous release of VEGF.
METHODS: A total of 18 rabbit model (length of stenosis: 3 cm) with anterior urethral stricture were used as experimental animals and divided into three groups. Group A as the control group: Simple BAMG scaffold materials for urethral reconstruction. Group B as the blank group: PLGA microspheres modified BAMG for urethral reconstruction. Group C: PLGA conjugated with VEGF and modified BAMG for the urethral reconstruction. All rabbits underwent urethral angiography after 7 days, 15 days, 1 month and 3 months after the operation, and one rabbit in each group was sacrificed to be prepared for the organization histologic examination, HE staining, masson staining, CD31, 34 and a-SAM immunohistochemical detection in the repaired sites.
RESULTS: In group A, significant urethral restenosis occurred in two rabbits after 15 days of the operation, HE and masson staining showed a lot of collagen arranged in the repaired sites, and there were a large number of inflammatory cell infiltration, and there were also CD31, 34 in the repaired sites. a-SAM microvascular tag count showed a small amount of microvascular; Group B showed anastomotic restenosis, HE and masoon staining showed inflammatory cell infiltration and collagen deposition; Group C: urethrography showed lumen patency. There were a small amount of inflammatory cell infiltration after 7 and 15 days after the operation, and there were also CD31, 34 in the repaired sites. The a-SAM microvascular tag count showed many microvascular. And the difference was significant.
CONCLUSIONS: Anterior urethral reconstruction with sustained-release of VEGF by PLGA nanospheres modified BAMG stents can reduce postoperative restenosis. It can also reduce collagen deposition and scar formation, promote angiogenesis of the repair tissue; therefore it in valuable in the tissue-engineered urethral reconstruction.
Copyright © 2013 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23711710     DOI: 10.1016/S1995-7645(13)60078-4

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  5 in total

Review 1.  Regenerative and engineered options for urethroplasty.

Authors:  Filippo Pederzoli; Gregory Joice; Andrea Salonia; Trinity J Bivalacqua; Nikolai A Sopko
Journal:  Nat Rev Urol       Date:  2019-06-06       Impact factor: 14.432

2.  Urethral reconstruction with autologous urine-derived stem cells seeded in three-dimensional porous small intestinal submucosa in a rabbit model.

Authors:  Yang Liu; Wenjun Ma; Bo Liu; Yangcai Wang; Jiaqiang Chu; Geng Xiong; Lianju Shen; Chunlan Long; Tao Lin; Dawei He; Denis Butnaru; Lyundup Alexey; Yuanyuan Zhang; Deying Zhang; Guanghui Wei
Journal:  Stem Cell Res Ther       Date:  2017-03-09       Impact factor: 6.832

Review 3.  Tissue engineering for urinary tract reconstruction and repair: Progress and prospect in China.

Authors:  Qingsong Zou; Qiang Fu
Journal:  Asian J Urol       Date:  2017-06-23

4.  IGF-1-releasing PLGA nanoparticles modified 3D printed PCL scaffolds for cartilage tissue engineering.

Authors:  Peiran Wei; Yan Xu; Yue Gu; Qingqiang Yao; Jiayin Li; Liming Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

5.  Encapsulated three-dimensional bioprinted structure seeded with urothelial cells: a new construction technique for tissue-engineered urinary tract patch.

Authors:  Yi-Peng Jin; Chong Shi; Yuan-Yi Wu; Ji-Lei Sun; Jiang-Ping Gao; Yong Yang
Journal:  Chin Med J (Engl)       Date:  2020-02-20       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.